Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announces that the Company will hold a conference call on Thursday, March 27, 2025 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2024.
Participants during the call will be:
Jonathan Dickinson, Chief Executive Officer
Sonia Quaratino, Executive Vice President, Chief Medical Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Details for the Virtual Event
The live webcast will be available at the following link:
https://events.q4inc.com/attendee/485278198
Participants may also join via telephone using the following registration link: https://registrations.events/direct/Q4I39065986
This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.
About Innate Pharma
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three therapeutic approaches: multi-specific NK Cell Engagers via its ANKET® (Antibody-based NK cell Engager Therapeutics) proprietary platform, Antibody Drug Conjugates (ADC) and monoclonal antibodies (mAbs).
Innate's portfolio includes several ANKET® drug candidates to address multiple tumor types as well as IPH4502, a differentiated ADC in development in solid tumors. In addition, anti-KIR3DL2 mAb lacutamab is developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, and anti-NKG2A mAb monalizumab is developed with AstraZeneca in non-small cell lung cancer.
Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients.
Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
Learn more about Innate Pharma at www.innate-pharma.com and follow us on LinkedIn and X.
Information about Innate Pharma shares
ISIN code Ticker code LEI
FR0010331421
Euronext: IPH Nasdaq: IPHA
9695002Y8420ZB8HJE29
Disclaimer on forward-looking information and risk factors
This press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including "anticipate," "believe," "can," "could," "estimate," "expect," "may," "might," "potential," "expect" "should," "will," or the negative of these and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company's reliance on third parties to manufacture its product candidates, the Company's commercialization efforts and the Company's continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties, which could cause the Company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Universal Registration Document filed with the French Financial Markets Authority ("AMF"), which is available on the AMF website http://www.amf-france.org or on Innate Pharma's website, and public filings and reports filed with the U.S. Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 20-F for the year ended December 31, 2023, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public by the Company. References to the Company's website and the AMF website are included for information only and the content contained therein, or that can be accessed through them, are not incorporated by reference into, and do not constitute a part of, this press release.
In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame or at all. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319202972/en/
Contacts
For additional information, please contact:Investors Innate Pharma Henry WheelerTel.: +33 (0)4 84 90 32 88Henry.wheeler@innate-pharma.fr
Media Relations NewCap Arthur RouilléTel.: +33 (0)1 44 71 00 15innate@newcap.eu
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Inspired and bet365 Launch Next-Gen Virtual Sports: V-Play NHL, NBA Re-Play, and Re-Play eSports
Inspired and bet365 add V-Play NFL, NBA Re-Play, and Re-Play eSports to their virtual sports line up NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. ('Inspired' or the 'Company') (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware, and services, is proud to announce the launch of three groundbreaking Virtual Sports titles – V-Play NHL, NBA Re-Play, and Re-Play eSports – available through bet365, one of the world's premier online gambling brands. These new products represent the next generation of Inspired's award-winning Virtual Sports portfolio, featuring cutting-edge motion capture, ultra-realistic animation, and non-stop action to deliver an engaging player experience. V-Play NHL is an officially licensed product that brings the speed and intensity of professional hockey into the virtual arena. Featuring real NHL teams and logos, the game delivers an authentic sports betting experience with broadcast-quality graphics and dynamic gameplay. NBA Re-Play, officially licensed by the NBA and the NBPA, uses iconic archive footage and advanced rendering technology to recreate unforgettable basketball moments. Fans can engage with the action in innovative ways, thanks to new betting formats and cinematic presentation. Re-Play eSports™ offers fast, always-on Counter-Strike: Global Offensive (CS:GO) virtual gameplay and betting opportunities for one of the most popular competitive video games globally and its captive audience of digitally native fans. The product utilizes official tournament archive footage from the Champion of Champions Tour, a top CS:GO event, with official in-game data and video feeds provided by data and technology company GRID. These new titles are part of Inspired's growing suite of officially licensed North American Virtual Sports products available through bet365, further reinforcing the companies' shared leadership in the space. 'We're excited to expand our partnership with bet365 through the launch of these groundbreaking products,' said Brooks Pierce, President & CEO of Inspired. 'With V-Play NHL, NBA Re-Play, and Re-Play eSports, we continue to redefine what's possible in Virtual Sports, delivering high-quality, immersive content that resonates with both fans and bettors.' 'Inspired continues to lead the way in Virtual Sports innovation,' said a bet365 spokesperson. 'With compelling visuals, official league integrations, and thrilling gameplay, these titles are set to be a major hit with our global audience.' The launch highlights the ongoing collaboration between Inspired and bet365 and their joint commitment to innovation and player-first entertainment. All three products are now live on bet365's global platform, fully optimized for desktop and mobile. 18+, Gambling can be addictive, please play responsibly. About Inspired Entertainment, Inc. Inspired offers an expanding portfolio of content, technology, hardware and services for regulated gaming, betting, lottery, social and leisure operators across land-based and mobile channels around the world. Inspired's gaming, virtual sports, interactive and leisure products appeal to a wide variety of players, creating new opportunities for operators to grow their revenue. Inspired operates in approximately 35 jurisdictions worldwide, supplying gaming systems with associated terminals and content for approximately 50,000 gaming machines located in betting shops, pubs, gaming halls and other route operations; virtual sports products through more than 32,000 retail venues and various online websites; digital games for 170+ websites; and a variety of amusement entertainment solutions with a total installed base of more than 16,000 terminals. Additional information can be found at About bet365 At bet365, we don't do ordinary. The original pioneers of In-Play betting, our world-class proprietary product, now extends to 96 sports and over 1,100,000 live streams globally. bet365 is committed to Safer Gambling. We promote gambling as an enjoyable leisure activity, and we believe that gambling can only remain this way if you stay in control and gamble responsibly. However, we know that for some people gambling can stop being a harmless leisure activity and become a problem. bet365 has a range of useful tools to help customers stay in control of their gambling that can be found at . GAMBLING PROBLEM? CALL OR TEXT 1-800-GAMBLER (AZ, CO, IN, IL, KS, LA, NC, NJ, OH, PA, TN, VA, KY) or 1-800-BETS OFF (IA). 21+ only (18+ in KY). Must be present in AZ/CO/IA/IN/KY/LA (select parishes) /NC/NJ/OH/PA/VA/KS. Forward-Looking Statements This news release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as 'anticipate,' 'believe,' 'expect,' 'estimate,' 'plan,' 'will,' 'would' and 'project' and other similar expressions that indicate future events or trends or are not statements of historical matters. These statements are based on Inspired's management's current expectations and beliefs, as well as a number of assumptions concerning future events. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of Inspired's control and all of which could cause actual results to differ materially from the results discussed in the forward-looking statements. Accordingly, forward-looking statements should not be relied upon as representing Inspired's views as of any subsequent date and Inspired does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as required by law. You are advised to review carefully the 'Risk Factors' section of Inspired's annual report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent quarterly reports on Form 10-Q, which are available, free of charge, on the U.S. Securities and Exchange Commission's website at and on Inspired's website at Contact: For InvestorsIR@ 646 620-6737 For Press and Sales inspiredsales@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
If You Buy O'Reilly Automotive With $10,000 in 2025, Will You Become a Millionaire in 10 Years?
Key Points O'Reilly will continue to benefit from the aging vehicle fleet, which requires more maintenance. The company sees strong demand regardless of the macro climate, reducing risk for shareholders. Shares trade at a historically expensive valuation, which limits the upside for returns. 10 stocks we like better than O'Reilly Automotive › O'Reilly Automotive (NASDAQ: ORLY) isn't an exciting business by any stretch of the imagination. In fact, this might be one of the most boring companies on the planet. It sells aftermarket auto parts to DIY and professional customers through physical stores. That's not a page-turning operational description. However, this retail stock's performance will get you up off your seat and cheering in no time. Over the past 30 years, shares have soared 42,650% (as of Aug. 15). An investment of $2,350 back then would be worth $1 million today. But if you were to buy $10,000 worth of O'Reilly stock in 2025, will you become a millionaire in 10 years? O'Reilly's bullish case O'Reilly's fantastic return comes from the fact that this is a great company. And I believe there are some key reasons why it's so great, all of which support the stock's bull case. For starters, O'Reilly benefits from durable industry tailwinds. The average age of cars on the road in the U.S. is now 12.5 years. It has steadily increased over the past two and a half decades. As these vehicles age and get past their original warranty, consumers must spend money on aftermarket parts to keep them in working condition. What's more, the number of cars on the road continues to increase. These long-lasting trends support O'Reilly's long-term growth prospects. Revenue rose at a compound annual rate of 8.3% in the past decade. And the business continues to open new stores, with 200 to 210 planned just in 2025. Another reason this is a high-quality business is the consistent demand that O'Reilly sees throughout an economic cycle. In strong economic times, when consumer confidence and spending are robust, people tend to drive more. This increases the wear and tear on their vehicles. As a result, there is a clear need for the parts and supplies O'Reilly stores sell. When a recession hits, unemployment rises, and consumers pull back on their spending, they certainly delay buying new vehicles. However, they still need their existing cars to work. This setup incentivizes spending on maintenance and upgrades. Again, O'Reilly benefits. Being able to perform well from a fundamental perspective in good and bad times makes O'Reilly an attractive investment. Nothing stands out quite like the fact that 2025 is shaping up to be the company's 33rd straight year of same-store sales growth. That's an unbelievable track record. Investors will also appreciate the management team's capital allocation policy. Because of O'Reilly's consistent profitability, it's left with excess cash. Executives have plowed this money into stock buybacks, which have helped reduce the diluted outstanding share count by 3.1% in the past year alone. Waiting for a 100-fold jump For this stock to turn a $10,000 investment into $1 million, its price would need to register a 100-fold rise. This might have been how O'Reilly shares performed in the past. However, it's not a realistic outcome as we look toward the future. And it definitely won't happen in the next decade. In fact, investors shouldn't bet the house on any single company helping them reach a $1 million portfolio balance. This outstanding business could continue to post double-digit earnings-per-share growth on a yearly basis. But it's at a much more mature stage of its lifecycle these days. Expecting the stock price to rise 100-fold is irrational. That doesn't mean O'Reilly doesn't deserve a place on your watch list. While the stock looks historically expensive at its current price-to-earnings ratio of 36.4, investors can wait for a pullback before scooping up shares. Do the experts think O'Reilly Automotive is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did O'Reilly Automotive make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,055% vs. just 183% for the S&P — that is beating the market by 871.03%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $654,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,076,588!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Neil Patel has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. If You Buy O'Reilly Automotive With $10,000 in 2025, Will You Become a Millionaire in 10 Years? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Applied Nutrition gives upbeat revenue update
UK sports-nutrition firm Applied Nutrition has said the company expects its revenue for its 2025 and 2026 fiscal years to be 'ahead of market expectations'. In a trading update yesterday (19 August), the maker of protein powders, bars and nutrition drinks provided a provisional estimate of its earnings for its financial year that recently closed on 31 July. Applied Nutrition anticipates revenue to have increased by 24% to £107m ($144.4m). The figure exceeds market forecasts of £100m. The company attributed the growth to 'strong' trading in the second half of the year, which contributed around £60m to its revenue. Adjusted earnings before interest, tax, depreciation, and amortisation (EBITDA) are projected to rise by 19% from £26m in the prior year. Additionally, net cash is expected to reach £18.5m, surpassing the market consensus of £16.6m. The company, which went public in October, credited its performance to the continued execution of its 'multi-pillar, global growth strategy'. Looking ahead, Applied Nutrition expects revenue for the financial year ending 31 July 2026 to also surpass market expectations. The board expressed confidence in the company's B2B-focused business model, stating that its core strengths will 'continue to drive sustained revenue growth and strong profitability over the long-term'. Applied Nutrition plans to release its audited results for the year ended 31 July on or around 10 November. Thomas Ryder, the CEO of Applied Nutrition, said: "We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations." Applied Nutrition offers four product ranges – Applied Nutrition, ABE, BodyFuel and Endurance – with over 100 products sold in more than 85 countries. The company operates a US division to support sales through retailer Walmart. It has marketing tie-ups with English and Scottish football clubs, professional boxers and MMA athletes. "Applied Nutrition gives upbeat revenue update" was originally created and published by Just Food, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
